Objective informational resource
for industry professionals

Вас может заинтересовать:

Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
WEB only
Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
Farmak successfully passed the scheduled inspection and received EU GMP certificates
WEB only
Farmak successfully passed the scheduled inspection and received EU GMP certificates
Within 7 days, the Polish regulatory authority inspected Farmak’s production for compliance with the requirements of Good Manufacturing Practice (GMP) of the European Union. As a result, the company received…
X

error

Подобається наш журнал! Розкажи про нас

RSS
Follow by Email
Facebook
Twitter
LinkedIn
LinkedIn
Share
Для копіювання будь-ласка увійдіть в свій аккаунт